FDA Releases Revised De Novo Pathway Guidance

On August 14, 2014, the U.S. Food and Drug Administration released an updated draft guidance document regarding de novo premarket review applications, De Novo Classification Process (Evaluation of Automatic Class III Designation).

Read More: FDA Releases Revised De Novo Pathway Guidance


Download PDF Share Back To Listing
Loading data